Overall survival and morbidity are not associated with advanced age for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a single centre experience.

Ernest ChengRaphael ShamavonianJasmine MuiRaymond HaylerJosh KarpesRuwanthi WijayawardanaShoma BaratNima AhmadiDavid L Morris

Published in: Pleura and peritoneum (2023)

In patients undergoing CRS/HIPEC, age of 70 and above does not impact OS or major morbidity but is associated with increased mortality. Age alone should not be a limiting factor in selecting CRS/HIPEC patients. Careful multi-disciplinary approach is needed when considering those of advanced age.

Keyphrases

patients undergoing
end stage renal disease
ejection fraction
chronic kidney disease
radiation therapy
acute coronary syndrome
risk factors
cardiovascular disease
type diabetes
cardiovascular events